Literature DB >> 2410708

Endothelium-mediated dilations contribute to the polarity of the arterial wall in vasomotion induced by alpha 2-adrenergic agonists.

H Matsuda, E Kuon, J Holtz, R Busse.   

Abstract

We tested whether or not an endothelium-mediated dilation is involved in the response of intact arteries to alpha-adrenergic stimulation, by separately applying agonists to the luminal or adventitial side of the arterial wall. Cumulative dose-response curves of the alpha 1-agonists l-phenylephrine or cirazoline applied luminally in rat tail arteries and in side branches of canine femoral arteries were identical to those obtained by adventitial application in the intact arteries, and were not modified by removal of the endothelium (eliminating acetylcholine-induced dilations). Constrictions induced by the alpha 2-agonists UK-14,304 or azepexole applied luminally were significantly lower than those induced by adventitial application, and were augmented significantly by removal of the endothelium. Half-maximally precontracted arteries were dilated by addition of alpha 2-agonists to the luminal perfusate; these dilations were abolished by removal of the endothelium. It is concluded that the functional polarity of the vascular wall of these arteries in response to alpha 2-agonists results from the release of a dilatory signal from the endothelial cells, counteracting the direct contractile activation of the adjacent smooth muscle cells by the agonists.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2410708     DOI: 10.1097/00005344-198507000-00011

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

1.  Minimal alpha 1- and alpha 2-adrenoceptor-mediated coronary vasoconstriction in the anaesthetized swine.

Authors:  R Schulz; R J Oudiz; B D Guth; G Heusch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-10       Impact factor: 3.000

2.  EDRF-mediated dilatation in the rat isolated perfused kidney: a microangiographic study.

Authors:  G A Burton; T M Griffith; D H Edwards
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

3.  Effect of endothelium on basal and alpha-adrenoceptor stimulated calcium fluxes in rat aorta.

Authors:  E Malta; V Schini; R C Miller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-09       Impact factor: 3.000

4.  Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension.

Authors:  B Egan; R Panis; A Hinderliter; N Schork; S Julius
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

Review 5.  The role of endothelium in the control of vascular tone.

Authors:  R Busse; G Trogisch; E Bassenge
Journal:  Basic Res Cardiol       Date:  1985 Sep-Oct       Impact factor: 17.165

6.  Effects of pre-contraction with endothelin-1 on alpha 2-adrenoceptor- and (endothelium-dependent) neuropeptide Y-mediated contractions in the isolated vascular bed of the rat tail.

Authors:  M R MacLean; J C McGrath
Journal:  Br J Pharmacol       Date:  1990-09       Impact factor: 8.739

7.  The role of alpha 1- and alpha 2-adrenoceptors in the coronary vasoconstrictor responses to neuronally released and exogenous noradrenaline in the dog.

Authors:  O L Woodman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-08       Impact factor: 3.000

8.  Local modulation of adrenergic responses in the hindlimb vasculature of the intact conscious rat.

Authors:  S E DiCarlo; R D Patil; H L Collins; C Y Chen
Journal:  J Physiol       Date:  1995-06-15       Impact factor: 5.182

Review 9.  Pharmacological mechanisms to attenuate sympathetically induced myocardial ischemia.

Authors:  R Schulz; B D Guth; G Heusch
Journal:  Cardiovasc Drugs Ther       Date:  1989-03       Impact factor: 3.727

Review 10.  Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy.

Authors:  James R Docherty; Martin Steinhoff; Dianne Lorton; Michael Detmar; Gregor Schäfer; Anna Holmes; Anna Di Nardo
Journal:  Adv Ther       Date:  2016-08-25       Impact factor: 3.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.